Joint International GMO Opposition Day A worldwide event is to be held on the 8th of April 2006, with the two-fold aim of informing people and demonstrating the front of concerned organizations against GMOs (both open-air plants and food). Thi […]
|
||||||
|
Submission from Third World Network to the Open-Ended Working Group of Legal and Technical Experts on Liability and Redress in the context of the Cartagena Protocol on Biosafety. […] This submission from the New Zealand Institute of Gene Ecology is to support Food Standards Australia/New Zealand’s preparation of an application to amend the Australia New Zealand Food Standards Code to allow foods derived from corn line LY038. […] What has been achieved with the BCH is remarkable but the BCH is NOT sufficient to all the tasks required under the Cartegena Biosafety Protocol, nor does it contain the reliable and comprehensive information necessary for biosafety decision-making. […] Item 1 The Associated Press, January 30, 2006 http://news.tmcnet.com/news/2006/01/30/1325378.htm Greece on Monday extended its ban on a variety of genetically modified corn seed developed by the U.S. biotech giant Monsanto, despite a […] While the biopharmaceutical industry as a whole has had some limited success, attempts to employ GE plants as a production platform for “plant-made pharmaceuticals” have foundered despite 15 years’ of field trials and huge infusions of capital. […] CBD moratorium on Terminator Technology reaffirmed, but with qualifications Granada, 28 January 2006 (Third World Network) – The fourth meeting of the Ad Hoc Open-ended Intersessional Working Group on Article 8(j) and related provisions of the […] Item 1 Renewed calls to ban Terminator Technology as CBD meets Kuala Lumpur, 23 January (Lim Li Ching) – As governments gather for the fourth meeting of the Ad Hoc Open-ended Intersessional Working Group on Article 8(j) and related pr […] Item 1 A New Wariness as the Risks Shift in Biotech Investing December 30, 2005 New York Times A New Wariness as the Risks Shift in Biotech Investing By ANDREW POLLACK WHEN it comes to biotechnology start-ups, venture ca […] |
||||||
|
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |
||||||